Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPNS lysolipid transporter 3 (SPNS3) is a predicted transmembrane protein belonging to the major facilitator superfamily (MFS), specifically within the spinster-like group of solute carrier transporters[2][5][7]. The protein is thought to enable transmembrane lysolipid and sphingolipid transport, including sphingosine-1-phosphate (S1P), although proof of direct functional activity in human cells is not yet robustly established[2][5][6]. It is a paralog of the better-studied SPNS2, which exports S1P and is vital for immune, vascular, and neural signaling; SPNS3 may serve overlapping or yet-unknown lipid transport roles. SPNS3 is expressed as a membrane protein, but to date, no direct involvement in human disease or as a therapeutic target has been described. It is used by researchers mainly in comparative and evolutionary studies of the spinster family of lipid transporters[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPNS lysolipid transporter 3 (SPNS3).